A detailed history of Ever Source Wealth Advisors, LLC transactions in Arvinas, Inc. stock. As of the latest transaction made, Ever Source Wealth Advisors, LLC holds 12 shares of ARVN stock, worth $221. This represents 0.0% of its overall portfolio holdings.

Number of Shares
12
Holding current value
$221
% of portfolio
0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

BUY
$23.66 - $32.73 $283 - $392
12 New
12 $0
Q2 2022

Aug 01, 2022

SELL
$36.01 - $74.24 $2,088 - $4,305
-58 Closed
0 $0
Q4 2021

Feb 07, 2022

BUY
$65.85 - $96.21 $3,819 - $5,580
58 New
58 $5,000

Others Institutions Holding ARVN

About ARVINAS, INC.


  • Ticker ARVN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 53,205,300
  • Market Cap $983M
  • Description
  • Arvinas, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. Its lead product candidates include Bavdegalutamide, a proteolysis targeting chimera (PROTAC) protein degrader that is in phase I clinical trial targeting the androgen receptor ...
More about ARVN
Track This Portfolio

Track Ever Source Wealth Advisors, LLC Portfolio

Follow Ever Source Wealth Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ever Source Wealth Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ever Source Wealth Advisors, LLC with notifications on news.